Compounding services can help your pharmacy stand out August 10, 2016 By Howard Larkin Dennis Song, RPh, describes the steps to take when starting a compounding services business. Why pharmacists are concerned about the safety of biosimilars Pharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products. Regs, robbery responses among top “pharmacy gamechangers” for 2016 August 10, 2016 By Howard Larkin The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016. The red pen rules: How to prevent pharmacy error Anxious new pharmacists get a shot in the arm from columnist Pete Kreckel, RPh. Drug take-back: A call for a permanent solution A coordinated effort needs to be made to preserve the health and safety of life on earth. Inside the U.S., European markets for biosimilars Despite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market. Biosimilars for cancer treatment on the U.S. horizon August 10, 2016 By Randy Dotinga Cancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment. Easing the bite from generic drug price increases Generic drug price hikes are not likely to disappear anytime soon. Find out why they're occurring and what can be done about them. Every pharmacist has them — and so does every teacher August 10, 2016 By David Stanley RPh What do pharmacists and teachers — and an awful lot of other people — have in common? Patient care comes first for McKesson’s 2016 Pharmacy of the Year winners August 10, 2016 By Howard Larkin McKesson recognized some outstanding community pharmacies at this year's IdeaShare.